Baidu, investors in talks to raise $2 billion for biotech startup | Tech News

Baidu, investors in talks to raise $2 billion for biotech startup

Baidu's plans come at a time of increased investment in the healthcare sector since the outbreak of the COVID-19 pandemic, with many companies expanding into online diagnosis options to fill the gaps left by overstretched, overcrowded hospitals.

By:REUTERS
| Updated on: Aug 20 2022, 22:50 IST
The Hang Seng Healthcare Index has surged about 40% over the past five months, outstripping the Hang Seng Index that edged up more than 6% over the time.
The Hang Seng Healthcare Index has surged about 40% over the past five months, outstripping the Hang Seng Index that edged up more than 6% over the time. (REUTERS)

Chinese tech giant Baidu is in talks with investors to raise up to $2 billion over three years for a biotech startup, which will use AI technology to discover new drugs and diagnose diseases, a person with direct knowledge of the matter said.

A second person confirmed the startup plan.

You may be interested in

MobilesTablets Laptops
7% OFF
Apple iPhone 15 Pro Max
  • Black Titanium
  • 8 GB RAM
  • 256 GB Storage
Google Pixel 8 Pro
  • Obsidian
  • 12 GB RAM
  • 128 GB Storage
34% OFF
Samsung Galaxy S23 Ultra 5G
  • Green
  • 12 GB RAM
  • 256 GB Storage
Apple iPhone 15 Plus
  • Black
  • 6 GB RAM
  • 128 GB Storage

Baidu is unlikely to be the controlling investor, the first person said. Both sources spoke on condition of anonymity, adding they did not have more details on the investment as talks were still underway.

Also read
Looking for a smartphone? To check mobile finder click here.

WeDoctor, backed by Tencent, Alibaba's healthcare arm and Ping An Good Doctor have joined the fray to develop apps that offer diagnosis, prescriptions, appointment bookings, 1-hour drug delivery and insurance.

But the startup under discussion plans to focus more on such areas as drug discovery and development, and early tumour diagnosis, by mobilising Baidu's powerful artificial intelligence (AI) technology that can perform complex computing to produce biological innovations, the sources said.

ALSO READ: Health tech pins hope on Africa's pandemic shift to online care

The name of the startup has not been decided, but Baidu came up with the idea as early as six months ago, one of the sources said, adding that Baidu founder and Chairman Robin Li has been personally involved in the project.

Baidu declined to comment.

Baidu open-sourced its Ribonucleic acid (RNA) prediction algorithm LinearFold this year. The tool aims to accelerate the prediction time of a virus' RNA secondary structure, which is crucial to understand a virus and develop vaccines.

The healthcare industry, especially biotechnology, has seen a flood of money flow in amid the scramble for a COVID-19 vaccine and governments seeking to fix their health systems.

The Hang Seng Healthcare Index has surged about 40% over the past five months, outstripping the Hang Seng Index that edged up more than 6% over the time.

Catch all the Latest Tech News, Mobile News, Laptop News, Gaming news, Wearables News , How To News, also keep up with us on Whatsapp channel,Twitter, Facebook, Google News, and Instagram. For our latest videos, subscribe to our YouTube channel.

First Published Date: 09 Sep, 13:48 IST
NEXT ARTICLE BEGINS